Finance Home - My Yahoo - Yahoo! - Help

Thursday, December 17, 2009, 12:34AM ET - U.S. Markets open in 8 hours and 56 minutes. Dow  0.10% Nasdaq  0.27%

Rosetta Genomics, Ltd. (ROSG)

On Dec 16: 2.04   0.02 (0.99%)

MORE ON ROSG

Quotes Summary Real-Time Options Historical Prices Charts Interactive Basic Chart Basic Tech. Analysis News & Info Headlines Financial Blogs Company Events Message Board Company Profile Key Statistics SEC Filings Competitors Industry Components Analyst Coverage Analyst Opinion Analyst Estimates Research Reports Star Analysts Ownership Major Holders Insider Transactions Insider Roster Financials Income Statement Balance Sheet Cash Flow

Industry: Diagnostic Substances Get Industry for:
ROSG SECTOR / INDUSTRY MEMBERSHIP Sector: Healthcare Industry: Diagnostic Substances INTRADAY PERFORMANCE SUMMARY Name Ticker Change Rosetta Genomics, Ltd. ROSG 0.99% Diagnostic Substances ^YHOh789 1.48% View Diagnostic Substances Industry Center DIAGNOSTIC SUBSTANCES INDUSTRY NEWS • Mintz joins Immucor board Wed 5:05 PM - at bizjournals.com • Immucor names Dr. Paul Mintz to board of directors Wed 4:46 PM - AP • Immucor Appoints New Board Director Wed 4:01 PM - PR Newswire • Immucor to Announce Fiscal Second Quarter Financial Results on Wednesday, January 6, 2010 Tue 4:01 PM - PR Newswire • EpiCept Provides Clinical and Business Update on Ceplene Program Tue 12:01 AM - Business Wire More Industry News... TOP DIAGNOSTIC SUBSTANCES COMPANIES BY MARKET CAP Company Symbol Price Change Market Cap P/E IDEXX Laboratories Inc. IDXX 52.31 1.23% 3.06B 27.71 Myriad Genetics Inc. MYGN 24.54 0.85% 2.36B 24.23 Immucor Inc. BLUD 19.89 0.00% 1.40B 18.23 Meridian Bioscience Inc. VIVO 21.73 0.98% 881.61M 27.26 AMAG Pharmaceuticals, Inc. AMAG 38.09 2.39% 652.60M N/A Rosetta Genomics, Ltd. ROSG 2.04 0.99% 28.91M N/A Showing 1 - 5 of 40 - View All More Top Companies: by Performance, by Valuation, by Growth, more... ROSG VS. INDUSTRY LEADERS Statistic Industry Leader ROSG ROSG Rank Market Capitalization IDXX 3.06B 28.91M 23 / 40 P/E Ratio (ttm) ABAX 41.27 N/A N/A PEG Ratio (ttm, 5 yr expected) SRDX 1.82 N/A Revenue Growth (Qtrly YoY) IMMU 696.10% N/A N/A EPS Growth (Qtrly YoY) QDEL 241.20% N/A N/A Long-Term Growth Rate (5 yr) AMAG 71% N/A N/A Return on Equity (ttm) IMMU 227.61% -61.06% 18 / 40 Long-Term Debt/Equity (mrq) N/A Dividend Yield (annual) VIVO 3.10% N/A N/A View Leaders & Laggards MORE ON DIAGNOSTIC SUBSTANCES • Industry Summary • News • Leaders & Laggards • Company List • Industry Calendar RELATED INDUSTRIES • Biotechnology • Drug Delivery • Drug Manufacturers - Major • Drug Manufacturers - Other • Drug Related Products • Drugs - Generic Top Performing Industries | Complete Industry List
Add to Portfolio     Set Alert     Email to a Friend Get Industry for Another Symbol: Symbol Lookup • Research Reports Screener • Industry Center